ABUS vs BA
Arbutus Biopharma Corp (ABUS) versus The Boeing Company (BA) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Not investment advice. Open the ABUS and BA stock pages for the full models.
Not investment advice.